| Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant F Zuo, H Abolhassani, L Du, A Piralla, F Bertoglio, L de Campos-Mata, ... Nature communications 13 (1), 2670, 2022 | 138 | 2022 |
| Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice R De Gasparo, M Pedotti, L Simonelli, P Nickl, F Muecksch, I Cassaniti, ... Nature 593 (7859), 424-428, 2021 | 122 | 2021 |
| Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients G Degiacomi, JC Sammartino, LR Chiarelli, O Riabova, V Makarov, ... International journal of molecular sciences 20 (23), 5868, 2019 | 121 | 2019 |
| Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant M Schubert, F Bertoglio, S Steinke, PA Heine, MA Ynga-Durand, H Maass, ... BMC medicine 20 (1), 102, 2022 | 87 | 2022 |
| Effect of different surface treatments on titanium dental implant micro-morphology G Marenzi, F Impero, F Scherillo, JC Sammartino, A Squillace, ... Materials 12 (5), 733, 2019 | 79 | 2019 |
| SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers F Rovida, I Cassaniti, S Paolucci, E Percivalle, A Sarasini, A Piralla, ... Nature communications 12 (1), 6032, 2021 | 65 | 2021 |
| In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates G Degiacomi, JC Sammartino, V Sinigiani, P Marra, A Urbani, MR Pasca Frontiers in microbiology 11, 559469, 2020 | 57 | 2020 |
| Immunity to SARS-CoV-2 up to 15 months after infection H Marcotte, A Piralla, F Zuo, L Du, I Cassaniti, H Wan, M Kumagai-Braesh, ... IScience 25 (2), 2022 | 55 | 2022 |
| White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds S Cabaro, V D’esposito, R Gasparro, F Borriello, F Granata, G Mosca, ... Platelets 29 (5), 463-467, 2018 | 53 | 2018 |
| A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal … A Lasagna, F Agustoni, E Percivalle, S Borgetto, A Paulet, G Comolli, ... ESMO open 6 (5), 100272, 2021 | 37 | 2021 |
| Micro-scale surface patterning of titanium dental implants by anodization in the presence of modifying salts G Marenzi, G Spagnuolo, JC Sammartino, R Gasparro, A Rebaudi, ... Materials 12 (11), 1753, 2019 | 37 | 2019 |
| Multitargeting compounds: a promising strategy to overcome multi-drug resistant tuberculosis G Stelitano, JC Sammartino, LR Chiarelli Molecules 25 (5), 1239, 2020 | 33 | 2020 |
| New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents LR Chiarelli, M Mori, G Beretta, A Gelain, E Pini, JC Sammartino, ... Journal of Enzyme Inhibition and Medicinal Chemistry 34 (1), 823-828, 2019 | 33 | 2019 |
| Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in∼ 40% of patients A Gervais, F Rovida, MA Avanzini, S Croce, A Marchal, SC Lin, A Ferrari, ... Journal of Experimental Medicine 220 (9), e20230661, 2023 | 28 | 2023 |
| An overview on the potential antimycobacterial agents targeting serine/threonine protein kinases from Mycobacterium tuberculosis M Mori, JC Sammartino, L Costantino, A Gelain, F Meneghetti, S Villa, ... Current Topics in Medicinal Chemistry 19 (9), 646-661, 2019 | 28 | 2019 |
| Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents L Liu, C Kong, M Fumagalli, K Savková, Y Xu, S Huszár, JC Sammartino, ... European journal of medicinal chemistry 208, 112773, 2020 | 27 | 2020 |
| Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design M Mori, G Stelitano, A Gelain, E Pini, LR Chiarelli, JC Sammartino, G Poli, ... Journal of Medicinal Chemistry 63 (13), 7066-7080, 2020 | 26 | 2020 |
| Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study I Cassaniti, F Bergami, E Percivalle, E Gabanti, JC Sammartino, A Ferrari, ... Clinical Microbiology and Infection 28 (2), 301. e1-301. e8, 2022 | 25 | 2022 |
| Macrophages and monocytes:“Trojan Horses” in COVID-19 E Percivalle, JC Sammartino, I Cassaniti, E Arbustini, M Urtis, A Smirnova, ... Viruses 13 (11), 2178, 2021 | 25 | 2021 |
| Fitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation R Colicchio, C Pagliuca, G Pastore, AG Cicatiello, C Pagliarulo, A Talà, ... Antimicrobial Agents and Chemotherapy 59 (12), 7637-7649, 2015 | 25 | 2015 |
IRENE CASSANITIResearcher, Microbiology and Virology Department, IRCCS Policlinico San Matteo在 universitadipavia.it 的电子邮件经过验证
